Variant report

Variant	esv3333264
Chromosome Location	chr1:169705778-169707626
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	FOS	chr1:169706590-169706791	MCF10A-Er-Src	breast:	n/a	n/a
2	FOS	chr1:169706648-169706793	MCF10A-Er-Src	breast:	n/a	n/a
3	FOS	chr1:169706652-169706853	MCF10A-Er-Src	breast:	n/a	n/a
4	JUN	chr1:169706613-169706895	HUVEC	blood vessel:	n/a	n/a
5	POLR2A	chr1:169706048-169706088	Gliobla	brain:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr1:169707608..169709249-chr1:169711620..169714505,2	MCF-7	breast:
2	chr1:169705648..169707388-chr1:169710933..169712519,2	MCF-7	breast:
3	chr1:169704931..169706505-chr1:169859799..169862220,2	K562	blood:

Variant related genes	Relation type
SELE	TF binding region

Extended variants
information (count: 57 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:57 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs77477043	chr1:169705782-169705783	Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
2	rs540755143	chr1:169705789-169705790	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs74717417	chr1:169705816-169705817	Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
4	rs536482583	chr1:169705835-169705836	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs189140970	chr1:169705845-169705846	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs563437703	chr1:169705883-169705884	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs148513945	chr1:169705907-169705908	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs552043460	chr1:169705958-169705959	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs566437327	chr1:169705993-169705994	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs28469136	chr1:169706030-169706031	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs141762844	chr1:169706059-169706060	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs568114800	chr1:169706080-169706081	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs78026016	chr1:169706082-169706083	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
14	rs10800469	chr1:169706083-169706084	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs568869954	chr1:169706095-169706096	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs140644007	chr1:169706111-169706112	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs181534151	chr1:169706156-169706157	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs73041432	chr1:169706200-169706201	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs111545902	chr1:169706210-169706211	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs147835635	chr1:169706250-169706251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs533884716	chr1:169706261-169706262	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs574029947	chr1:169706322-169706323	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs75414703	chr1:169706379-169706380	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
24	rs12086677	chr1:169706424-169706425	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs12041598	chr1:169706448-169706449	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs567374206	chr1:169706477-169706478	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs545719594	chr1:169706504-169706505	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs199758355	chr1:169706528-169706529	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs564010806	chr1:169706532-169706533	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs528287486	chr1:169706539-169706540	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs540383519	chr1:169706548-169706549	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs550288373	chr1:169706551-169706552	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs561633094	chr1:169706564-169706565	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs12039207	chr1:169706580-169706581	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs200761217	chr1:169706608-169706609	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs75337769	chr1:169706681-169706682	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
37	rs550397817	chr1:169706754-169706755	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs184656509	chr1:169706793-169706794	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs76249441	chr1:169706824-169706825	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
40	rs375440471	chr1:169706969-169706970	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs567127542	chr1:169706985-169706986	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs190323270	chr1:169707010-169707011	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs78636154	chr1:169707011-169707012	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
44	rs79301351	chr1:169707050-169707051	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs79709859	chr1:169707103-169707104	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
46	rs76853522	chr1:169707151-169707152	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
47	rs544967800	chr1:169707153-169707154	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs114028967	chr1:169707170-169707171	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs181410925	chr1:169707234-169707235	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs76036595	chr1:169707243-169707244	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance

Variant related diseases (count:92)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	16750200	CNVD
Liposarcoma	21253554	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	21183584	CNVD
Multiple myeloma	16461302	CNVD
Rett syndrome	21593744	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21829676	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Bladder cancer	19088036	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Retinoblastoma	19183342	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chordoma	18071362	CNVD
Hepatocellular carcinoma	18803288	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Urothelial carcinoma	21177765	CNVD
Burkitt''s lymphoma	19759907	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Trisomy 5 syndrome	21098271	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Breast cancer	21611746	CNVD
Neuroblastoma	18923191	CNVD
Soft tissue tumor	16732325	CNVD
Cancer	17060936	CNVD
Lung cancer	16740712	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Williams-beuren syndrome	16971481	CNVD
Developmental delay	21147756	CNVD
Burkitt''s lymphoma	20823134	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Lung cancer	18438408	CNVD
Cancer	20164920	CNVD

Chromatin state (count:20 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:169703800-169707800	Weak transcription	HUVEC	blood vessel
2	chr1:169706000-169706400	Enhancers	iPS-15b Cell Line	embryonic stem cell
3	chr1:169706000-169706400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr1:169706000-169706400	Enhancers	Liver	Liver
5	chr1:169706000-169707000	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr1:169706400-169706800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
7	chr1:169706400-169706800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
8	chr1:169706400-169710200	Weak transcription	Liver	Liver
9	chr1:169706800-169707000	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr1:169706800-169707000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr1:169706800-169707200	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr1:169706800-169707400	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr1:169706800-169707400	Enhancers	iPS-20b Cell Line	embryonic stem cell
14	chr1:169707000-169710200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
15	chr1:169707000-169710200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
16	chr1:169707000-169710400	Weak transcription	HUES48 Cell Line	embryonic stem cell
17	chr1:169707200-169708000	Enhancers	Left Ventricle	heart
18	chr1:169707200-169710400	Weak transcription	HUES64 Cell Line	embryonic stem cell
19	chr1:169707400-169710400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
20	chr1:169707400-169710600	Weak transcription	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links